Bulletin
Investor Alert

Clarus Therapeutics Holdings Inc.

NAS: CRXT

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Dec 3, 2021, 7:44 p.m.

/zigman2/quotes/223252698/composite

$

4.40

Change

-0.07 -1.57%

Volume

Volume 2,604

Quotes are delayed by 20 min

/zigman2/quotes/223252698/composite

Previous close

$ 4.96

$ 4.47

Change

-0.49 -9.88%

Day low

Day high

$4.43

$5.37

Open

52 week low

52 week high

$3.43

$31.24

Open

Company Description

Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. the company's first commercial product is JATENZO. It is headquartered in Northbrook, IL.

Valuation

P/E Ratio (with extraordinary items)

109.16

Enterprise Value to EBITDA

-34.13

Enterprise Value to Sales

25.09

Efficiency

Liquidity

Current Ratio

1.96

Quick Ratio

1.96

Cash Ratio

1.56

Profitability

Capital Structure

Officers and Executives

Name Age Officer Since Title
Dr. Robert E. Dudley 65 - President, Chief Executive Officer & Director
Mr. Richard D. Peterson 52 - Chief Financial Officer
Dr. Jay Newmark - - Chief Medical Officer
Mr. Steven A. Bourne 58 - Chief Administrative Officer
Mr. Frank Jaeger 50 - Chief Commercial Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
09/17/2021 Bracebridge Capital LLC
127,360   Disposition at $9.2 per share. 1,171,712
09/09/2021 Blue Water Sponsor LLC
Director
135,000   0
09/09/2021 Blue Water Sponsor LLC
Director
1,437,500   Derivative/Non-derivative trans. at $0 per share. 0
09/09/2021 Robert E. Dudley
Chief Executive Officer; Director
4,566   Award at $0 per share. 0
09/09/2021 Steven A. Bourne
Chief Administrative Officer
1,305   Award at $0 per share. 0
09/09/2021 H.I.G. BioHealth Partners LLC
2,470,756   Award at $0 per share. 0
09/09/2021 H.I.G. BioHealth Partners LLC
2,731,094   Award at $0 per share. 0
09/09/2021 H.I.G. BioHealth Partners LLC
490,531   Award at $0 per share. 0
09/09/2021 H.I.G. BioHealth Partners LLC
2,470,756   Award at $0 per share. 0
09/09/2021 H.I.G. BioHealth Partners LLC
2,731,094   Award at $0 per share. 0
09/09/2021 H.I.G. BioHealth Partners LLC
490,531   Award at $0 per share. 0
/news/latest/company/us/crxt

MarketWatch News on CRXT

  1. Clarus Therapeutics started at buy with $10 stock price target at Truist

    7:36 a.m. Oct. 13, 2021

    - Tomi Kilgore

  2. Clarus Therapeutics initiated at buy with $13 price target at Maxim

    7:00 a.m. Sept. 29, 2021

    - Tonya Garcia

  3. Clarus Therapeutics started at outperform with $12 stock price target at Oppenheimer

    6:37 a.m. Sept. 20, 2021

    - Tomi Kilgore

/news/nonmarketwatch/company/us/crxt

Other News on CRXT

  1. NBEV, AUR and GTEC among mid-day movers

    12:31 p.m. Nov. 23, 2021

    - Seeking Alpha

  2. 10-Q: CLARUS THERAPEUTICS HOLDINGS, INC.

    4:42 p.m. Nov. 19, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  3. JP, HCDI and PETZ among mid-day movers

    12:48 p.m. Nov. 4, 2021

    - Seeking Alpha

  4. STAB, RLX and GWH among mid-day movers

    11:31 a.m. Oct. 13, 2021

    - Seeking Alpha

  5. CLLS, BBIG and GNLN among pre market gainers

    7:26 a.m. Oct. 13, 2021

    - Seeking Alpha

  6. ACST, NURO and ANY among mid-day movers

    12:45 p.m. Aug. 30, 2021

    - Seeking Alpha

  7. Midday Market Update: Why Are Stocks Down Today?

    11:05 a.m. Aug. 26, 2021

    - InvestorPlace.com

  8. Loading more headlines...

At a Glance

Clarus Therapeutics Holdings, Inc.

555 Skokie Boulevard

Suite 340

Northbrook, Illinois 60062

Phone

-

Industry

-

Sector

-

Fiscal Year-end

12/2021

Revenue

N/A

Net Income

$-4.72M

Employees

-

/news/pressrelease/company/us/crxt

Press Releases on CRXT

  1. Clarus Therapeutics Announces $15 Million Private Placement

    9:05 a.m. Dec. 3, 2021

    - GlobeNewswire

  2. Biotech Winners Emerging Amid Sector's Current Bearish Run

    9:57 a.m. Oct. 14, 2021

    - Baystreet.ca

  3. Loading more headlines...
Trending Tickers
  • /zigman2/quotes/200172674/composite EDSA+102.72%
  • /zigman2/quotes/209901640/composite SPY-1.67%
  • /zigman2/quotes/201343976/composite UVXY+16.31%
  • /zigman2/quotes/221104327/composite LCID+4.83%
  • /zigman2/quotes/214109287/composite SDC-3.13%
X
Powered by StockTwits
Link to MarketWatch's Slice.